Cargando…

Cancer patients and coronavirus disease 2019: evidence in context

In the rapidly evolving coronavirus disease 2019 (COVID-19) outbreak, inherent literature has been increasing at an impressive rate. Such a dynamic scenario imposes the necessity to define a new framework for cancer care. The first emerging evidence has transmitted contrasting messages with regards...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barba, Maddalena, Krasniqi, Eriseld, Ciliberto, Gennaro, Vici, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429080/ https://www.ncbi.nlm.nih.gov/pubmed/32799883 http://dx.doi.org/10.1186/s12967-020-02483-w

Ejemplares similares

Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors
por: Vici, Patrizia, et al.
Publicado: (2020)

Burnout of health care providers during the COVID-19 pandemic: Focus on Medical Oncologists
por: Vici, Patrizia, et al.
Publicado: (2021)

Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case report
por: Barchiesi, Giacomo, et al.
Publicado: (2019)

COVID‐19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience
por: Barba, Maddalena, et al.
Publicado: (2021)

Case report: 5-year progression free survival and complete liver response in a patient with metastatic breast cancer treated with everolimus plus exemestane
por: Krasniqi, Eriseld, et al.
Publicado: (2020)

Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer
por: Mazzotta, Marco, et al.
Publicado: (2019)

Neoadjuvant Immune-Checkpoint Blockade in Triple-Negative Breast Cancer: Current Evidence and Literature-Based Meta-Analysis of Randomized Trials
por: Marinelli, Daniele, et al.
Publicado: (2020)

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios
por: Pizzuti, Laura, et al.
Publicado: (2019)

Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives
por: Barchiesi, Giacomo, et al.
Publicado: (2020)

Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration
por: Krasniqi, Eriseld, et al.
Publicado: (2022)

Observational Multicenter Study on the Prognostic Relevance of Coagulation Activation in Risk Assessment and Stratification in Locally Advanced Breast Cancer. Outline of the ARIAS Trial
por: Pizzuti, Laura, et al.
Publicado: (2020)

Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting
por: Grassadonia, Antonino, et al.
Publicado: (2021)

DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study
por: Bon, Giulia, et al.
Publicado: (2023)

Breast cancer surgery during the Covid-19 pandemic: a monocentre experience from the Regina Elena National Cancer Institute of Rome
por: Pelle, Fabio, et al.
Publicado: (2020)

Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer
por: Pallocca, Matteo, et al.
Publicado: (2018)

Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?
por: Mazzotta, Marco, et al.
Publicado: (2021)

Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future Perspectives
por: Krasniqi, Eriseld, et al.
Publicado: (2021)

Proposal for Coronavirus Disease 2019 Management
por: Downs, John B., et al.
Publicado: (2020)

Colorectal Cancer Screening in the Novel Coronavirus Disease-2019 Era
por: Dekker, Evelien, et al.
Publicado: (2020)

Clinical Distancing and Mitigation of Coronavirus Disease 2019
por: Scott, Benjamin K., et al.
Publicado: (2020)

Thromboprophylaxis for medical inpatients with coronavirus disease 2019
por: Dalager-Pedersen, M., et al.
Publicado: (2020)

Commentary: The molecular pandemonium of coronavirus disease 2019
por: Balsam, Leora B., et al.
Publicado: (2021)

Is It Time for Coronavirus Disease-2019 Vaccine Mandates?
por: Bernstein, Henry H., et al.
Publicado: (2022)

Which are the best coronavirus disease 2019 vaccines?
por: Omrani, Ali S., et al.
Publicado: (2021)

Treating Gastrointestinal Cancer During the Coronavirus Disease 2019 Pandemic in Europe
por: Collienne, Maike, et al.
Publicado: (2020)

Diagnosis and treatment strategy of coronavirus disease 2019 with cardiovascular disease in elderly patients
por: Cheng, Biao
Publicado: (2020)

Patients With Lung Cancer and Coronavirus Disease 2019 Epidemic: An Experience From an Italian University Hospital
por: Scagliotti, Giorgio, et al.
Publicado: (2020)

Caring for Pediatric Patients with Diabetes amidst the Coronavirus Disease 2019 Storm
por: Ho, Cindy, et al.
Publicado: (2020)

Does Pulmonary Aspergillosis Complicate Coronavirus Disease 2019?
por: Beer, Karlyn D., et al.
Publicado: (2020)

Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key
por: Yu, Jiangquan, et al.
Publicado: (2021)

Preparedness for further boosting coronavirus disease 2019 vaccines
por: Lim, So Yun, et al.
Publicado: (2022)

Emerging role of S-1 in gastric cancer
por: Krasniqi, Eriseld, et al.
Publicado: (2015)

Bats and Coronaviruses in the Context of COVID-19
por: Wang, Linfa, et al.
Publicado: (2021)

Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes
por: Mazzotta, Marco, et al.
Publicado: (2020)

How the Coronavirus Disease-2019 May Improve Care: Rethinking Cervical Cancer Prevention
por: Feldman, Sarah, et al.
Publicado: (2020)

Implications of current and future approaches to coronavirus disease 2019 testing
por: Smith, Rasheid, et al.
Publicado: (2020)

The role of a Coronavirus disease 2019 pharmacist: an Australian perspective
por: Nguy, Jenny, et al.
Publicado: (2020)

Therapeutic potential of inhalable medications to combat coronavirus disease-2019
por: Parvathaneni, Vineela, et al.
Publicado: (2020)

Coronavirus Disease 2019 and Vaccination of Children and Adolescents: Prospects and Challenges
por: Zimet, Gregory D., et al.
Publicado: (2021)

Commentary: Training in the time of coronavirus disease 2019 (COVID-19)
por: Tibayan, Frederick A.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sets0qqrm4lbqt7qcgel04fd88